Evidence map›Paper›PMID 31113864›Full record

ArticleThe Journal of biological chemistry2019

RIP2 promotes FcγR-mediated reactive oxygen species production.

Michael G Shehat, Omar A Cardona, George F Aranjuez, Mollie W Jewett, Justine T Tigno-Aranjuez

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. NOD2-NLRP3 Axis and Asthma.Journal of asthma and allergy · 2025
    Review
  3. Article
  4. Article
  5. Analysis of miRNA Expression Profiling ofInternational journal of molecular sciences · 2022
    Article
  6. Transcriptional Regulation ofInternational journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Michael G ShehatFrom the Immunity and Pathogenesis Division, Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, Florida 32827.
Omar A CardonaFrom the Immunity and Pathogenesis Division, Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, Florida 32827.
George F AranjuezFrom the Immunity and Pathogenesis Division, Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, Florida 32827.
Mollie W JewettFrom the Immunity and Pathogenesis Division, Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, Florida 32827.
Justine T Tigno-AranjuezFrom the Immunity and Pathogenesis Division, Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, Florida 32827 justine.tigno-aranjuez@ucf.edu.ORCID 0000-0002-6843-7490
University of Central Florida · US

Funding

Determination of the genetic basis for B. burgdorferi mammalian infectivityR01AI099094 · NIAID · UNIVERSITY OF CENTRAL FLORIDA · PI Mollie W Jewett · 2013 to 2026
$4.0M
The Role of RIP2 Kinase in the Pathogenesis of Allergic AsthmaR00HL122365 · NHLBI · UNIVERSITY OF CENTRAL FLORIDA · PI TIGNO-ARANJUEZ, JUSTINE TIGLAO · 2015 to 2017
$740k
NHLBI NIH HHS R00 HL122365NIAID NIH HHS R01 AI099094
6 · The paper itself

Abstract

Receptor-interacting protein 2 (RIP2) is a kinase that mediates signaling downstream of the bacterial peptidoglycan sensors NOD1 and NOD2. Genetic loss or pharmaceutical inhibition of RIP2 has been shown to be beneficial in multiple inflammatory disease models with the effects largely attributed to reducing proinflammatory signaling downstream of peptidoglycan recognition. However, given the widespread expression of this kinase and its reported interactions with numerous other proteins, it is possible that RIP2 may also function in roles outside of peptidoglycan sensing. In this work, we show that RIP2 undergoes tyrosine phosphorylation and activation in response to engagement of the Fc γ receptor (FcγR). Using bone marrow-derived macrophages from WT and RIP2-KO mice, we show that loss of RIP2 leads to deficient FcγR signaling and reactive oxygen species (ROS) production upon FcγR cross-linking without affecting cytokine secretion, phagocytosis, or nitrate/nitrite production. The FcγR-induced ROS response was still dependent on NOD2, as macrophages deficient in this receptor showed similar defects. Mechanistically, we found that different members of the Src family kinases (SFKs) can promote RIP2 tyrosine phosphorylation and activation. Altogether, our findings suggest that RIP2 is functionally important in pathways outside of bacterial peptidoglycan sensing and that involvement in such pathways may depend on the actions of SFKs. These findings will have important implications for future therapies designed to target this kinase.

Indexed as

AnimalsCytokinesImmunity, InnateMacrophagesMaleMiceMice, Inbred C57BLMice, KnockoutPhagocytosisPhosphorylationReactive Oxygen SpeciesReceptor-Interacting Protein Serine-Threonine Kinase 2Receptors, IgGSignal TransductionCytokinesFcgr1 protein, mouseReactive Oxygen SpeciesReceptor-Interacting Protein Serine-Threonine Kinase 2Receptors, IgGRipk2 protein, mouseFc receptorFc-γ receptorinflammationreactive oxygen species (ROS)receptor interacting protein 2 (RIP2)signal transductionSrc

Identifiers

PMID31113864
PMCPMC6664193
OpenAlexW2944981796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.